biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > How Profound!

<< Previous

Bullboard Posts

Next >>

Comment by JDavenporton Jul 27, 2022 10:06pm

558 Views

Post# 34855771

RE:RE:RE:How Profound!

Well, votes do count, beenthere. In only two years I am approaching 3000 thumbs-up. They would matter to you if you had that many.

But reads per post are more accurate. My lowest number of reads come when I respond to you and the other trolls, but I still get more than you do on your own posts.

I remain pleased with the interest shown by the number of reads of my other posts.

jd

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec